PURPOSE: To compare the intraocular pressure (IOP) of patients infected with human immunodeficiency virus (HIV) and treated with highly active antiretroviral therapy (HAART) to a control group and to determine whether HAART reverses the previously reported reduction in IOP associated with HIV infection. DESIGN: Retrospective case control study. METHODS: Review of patients with HIV infection on HAART compared with a matched control group. RESULTS: Among 64 patients and 56 control subjects, no significant difference in IOP was found (P =.520), nor was correlation noted between IOP and either CD4+ T-lymphocyte counts, or viral load. CONCLUSION: When HIV infection is treated with HAART, IOP is not significantly different from that of control subjects.
PURPOSE: To compare the intraocular pressure (IOP) of patients infected with human immunodeficiency virus (HIV) and treated with highly active antiretroviral therapy (HAART) to a control group and to determine whether HAART reverses the previously reported reduction in IOP associated with HIV infection. DESIGN: Retrospective case control study. METHODS: Review of patients with HIV infection on HAART compared with a matched control group. RESULTS: Among 64 patients and 56 control subjects, no significant difference in IOP was found (P =.520), nor was correlation noted between IOP and either CD4+ T-lymphocyte counts, or viral load. CONCLUSION: When HIV infection is treated with HAART, IOP is not significantly different from that of control subjects.